Natasha Giordano
CIK 1315585 · Chief Executive Officer · last filed 2025-12-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$168.8K
Companies
5
Total Filings
25
Lifetime Open-Market Net
-$62.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OGEN | Director | — | $0.62 | — | $0 | 1 | 2025-12-15 |
| MTNB | Director | — | $0.78 | — | $0 | 3 | 2023-11-03 |
| PLx Pharma Inc. (PLXP) Delisted | Chief Executive Officer | 5,186 | $0.09 | $451 | $15.0K | 8 | 2022-03-16 |
| ACET | Director | 20,972 | $8.05 | $168.8K | -$77.2K | 9 | 2017-12-11 |
| DENDRITE INTERNATIONAL INC (DRTE) Delisted | Pres., Global Business Unit | 75,204 | — | — | $0 | 2 | 2007-05-03 |
Recent Filings · Page 2 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-18 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-11 | ACET | Grant (A) | +6,737 | $70.0K | EDGAR |
| 2017-08-14 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-20 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | +1,086 | $0 | EDGAR |
| 2016-12-05 | ACET | Grant (A) | +3,467 | $70.0K | EDGAR |
| 2015-12-16 | ACET | Grant (A) | +2,711 | $70.0K | EDGAR |
| 2015-03-05 | ACET | Sell (S) | −2,164 | -$45.3K | EDGAR |
| 2014-12-05 | ACET | Grant (A) | +2,169 | $48.0K | EDGAR |
| 2014-09-09 | ACET | Sell (S) | −1,453 | -$31.9K | EDGAR |
| 2013-12-06 | ACET | Grant (A) | +2,164 | $48.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.